[Effects of Butylphthalide on airway mucus hypersecretion, IL-13 and TNF-α in asthmatic mice]

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2021 Sep;37(5):557-560. doi: 10.12047/j.cjap.6125.2021.049.
[Article in Chinese]

Abstract

Objective: To investigate the effects of Butylphthalide (NBP) on airway mucus hypersecretion, interleukin-13 (IL-13) and tumor necrosis factor-α (TNF-α) in asthmatic mice. Methods: The mice were randomly divided into control group, asthma group, DEX group and high, medium and low doses of NBP (100, 50, 25 mg/kg) groups (n=12). Ovalbumin (OVA) injection was sensitized on the 1st, 8th, and 15th day of the experiment, and OVA was inhaled on the 22nd day to stimulate for 5 weeks to replicate the asthma model, and 20 mg/kg of NBP was given for intervention before the challenge. Finally, the asthma behavior, the secretion of goblet cells and Mucin 5ac (Muc5ac)were observed, and meanwhile the viscosity of bronchoalveolar lavage fluid (BALF) and the levels of Muc5ac, IL-13 and TNF-α in BALF were measured by ELISA. Results: Compared with the control group, the degree of sneezing, nose scratching and asthma, the proliferation of airway epithelial goblet cells and secretion of Muc5ac in the asthma group were increased significantly (P<0.01), meanwhile, the viscosity of BALF and the contents of Muc5ac, IL-13 and TNF-α were also increased significantly (P<0.01). Compared with the asthma group, the above behavioral scores of asthma were decreased significantly (P<0.01) after the intervention of 25, 50 and 100 mg/kg NBP, as well as the proliferation of airway epithelial goblet cells, secretion of Muc5ac, the viscosity of BALF and the contents of Muc5ac, IL-13 and TNF-α were significantly lower than those of the asthma group (P<0.05, 0.01). Conclusion: NBP has the effect of anti-asthma by inhibiting mucus hypersecretion, and one of its mechanisms is to alleviate the abnormal expressions of IL-13 and TNF-α.

目的: 研究丁苯酞对哮喘小鼠气道黏液高分泌及白介素-13(IL-13)、肿瘤坏死因子-α(TNF-α)的影响。方法: 小鼠随机分为空白对照组、模型对照组、阳性对照组和丁苯酞高、中、低剂量(100、50、25 mg/kg)组(n=12)。实验第1日、8日、15日通过注射卵清白蛋白(OVA)致敏,第22日吸入OVA连续激发5周复制哮喘模型,同时在激发前给予丁苯酞20 mg/kg进行干预,观测哮喘行为学、气道杯状细胞及黏蛋白5ac(Muc5ac)的分泌,测定支气管肺泡灌洗液(BALF)粘度,采用ELISA法测定BALF中Muc5ac、IL-13及TNF-α的水平。结果: 与空白对照组比较,模型对照组小鼠打喷嚏、抓鼻及哮喘的程度显著加重(P<0.01),小鼠气道上皮杯状细胞增生及Muc5ac的分泌显著增加(P<0.01),BALF的粘度及其中的Muc5ac、IL-13和TNF-α的含量显著升高(P<0.01);与模型对照组比较,25、50、100 mg/kg丁苯酞干预后哮喘行为学评分明显下降(P<0.01);小鼠气道上皮杯状细胞增生、Muc5ac的分泌、BALF的粘度及其中的Muc5ac、IL-13和TNF-α的含量均明显降低(P<0.05, 0.01)。结论: 丁苯酞具有抑制哮喘气道黏液高分泌而平喘的作用,缓解IL-13、TNF-α异常高表达是其抑制气道黏液高分泌的作用机制之一。.

Keywords: Butylphthalide (NBP); asthma; interleukin-13 (IL-13); mouse; mucus hypersecretion; tumor necrosis factor-α (TNF-α).

MeSH terms

  • Animals
  • Asthma* / chemically induced
  • Asthma* / drug therapy
  • Benzofurans
  • Bronchoalveolar Lavage Fluid
  • Disease Models, Animal
  • Interleukin-13*
  • Lung
  • Mice
  • Mice, Inbred BALB C
  • Mucus
  • Ovalbumin
  • Tumor Necrosis Factor-alpha

Substances

  • Benzofurans
  • Interleukin-13
  • Tumor Necrosis Factor-alpha
  • 3-n-butylphthalide
  • Ovalbumin